Prosecution Insights
Last updated: November 20, 2026
Application No. 19/180,459

LIQUID COMPOSITION WITH PERFUME CAPSULES

Non-Final OA §103§112
Filed
Apr 16, 2025
Priority
Apr 22, 2024 — EU 24171723.0
Examiner
OGDEN JR, NECHOLUS
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
The Procter & Gamble Company
OA Round
1 (Non-Final)
70%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
737 granted / 1056 resolved
+4.8% vs TC avg
Strong +24% interview lift
Without
With
+23.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
48 currently pending
Career history
1109
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
47.6%
+7.6% vs TC avg
§102
19.6%
-20.4% vs TC avg
§112
14.8%
-25.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1056 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 7 and 8 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claims 7 and 8 depend from 1 and comprise additional . Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-20 is/are rejected under 35 U.S.C. 103 as being unpatentable over CN (110699194) in view of Souter et al (2016/355767). CN ‘194 is concerned with stable dispersing of microcapsule essence in laundry liquid composition so that the long lasting perfume effect will not be affected ([0001] and [0003]). CN ‘194 discloses a liquid composition comprising (table 1, Ex4): ii) from more than 5% to 90% by weight of the composition of an alcohol alkoxylated nonionic surfactant (c12-14 fatty alcohol EO9, 40 wt%; modified long chain fatty alcohol polyoxyethylene ether, 2 wt%); iii) less than 20% by weight of the composition of polyethylene glycol having a number average molecular weight of from 200 Da to 1000 Da and/or less than 4% by weight of the composition of propylene glycol (PEG 200-1000, 0 wt%; propylene glycol, 0 wt%); iv) from 1 to 50% by weight of the composition of perfume capsules (microcapsule flavor, 5 wt%; page 5, paragraph 1); v) from 1 to 25% by weight of the composition of water (20 wt%); and vi) less than 5% by weight of the composition of anionic surfactant (0 wt%) among other ingredients. CN ‘194 does not disclose a unit-dose article comprising a water-soluble film creating a first compartment and a second compartment. Souter et al disclose a liquid laundry detergent formulated into a unit dose article (claim 1 and [0020]) divided into two compartments ([0126]), which is fully enclosed by a water soluble film such as PVA ([0130]). Souter discloses a liquid laundry detergent (table 1, composition A-C) comprising: anionic and non-ionic surfactants, enzyme such as protease, free perfumes and organic solvents such as dipropylene glycol, glycerol among other ingredients. It would have been obvious to the skilled artisan to substitute the single compartment for a multicompartment to isolate ingredients for purposes known in the laundry art and delivery of ingredients as suggested by Souter et al. Claim(s) 1-20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Baustista Cid et al (10240111) in view of Souter et al (2016/355767). Baustista Cid et al is concerned with liquid laundry additive composition (claim 1; column 2, lines 4-9) such as scent booster and the corresponding method to wash clothes (column 1, lines 37-42). Baustista Cid et al discloses a liquid composition comprising (Ex1, inventive): polyethylene glycol fatty alcohol ethers (3.2 wt%; claim 17, feature d), polyethylene glycol fatty acid esters (9.6 wt%); iii) less than 20% by weight of the composition of polyethylene glycol having a number average molecular weight of from 200 Da to 1000 Da and/or less than 4% by weight of the composition of propylene glycol (PEG 200-1000, 0 wt%; propylene glycol, 0 wt%); iv) from 1 to 50% by weight of the composition of perfume capsules (encapsulated perfume, 3 wt%); v) from 1 to 25% by weight of the composition of water (0 wt%); vi) less than 5% by weight of the composition of anionic surfactant (0 wt%); PEG 2000-10K (30 wt%; claim 8) and glycerin (4 wt%) among other products. The subject-matter of said claim 1 therefore differs from this known liquid laundry detergent in that (ii) the concentration range of alcohol alkoxylated nonionic surfactant falls within 5-90 wt% and the multicompartment unit dose. It would have been obvious to optimize the alkoxylated nonionic surfactant even outside of the range of 5% given that optimization is within the level of the ordinary skilled artisan. With respect to the compartment, one skilled in the art would have utilized the multicompartment to deliver and isolate the chemicals within the laundry application in a systemic manner consistent with the known process of the art. [W]hen a patent 'simply arranges old elements with each performing the same function it had known to perform' and yields no more than one would expect from such an arrangement, the combination is obvious. [KSR Int'l Co. v.Teleflex Inc., 550 U.S. at 418 (quoting Sakraida v. Ag Pro, Inc., 425 U.S. 273,282 (1976).] Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to NECHOLUS OGDEN JR whose telephone number is (571)272-1322. The examiner can normally be reached 8-4:30 EST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at 571-272-1498. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NECHOLUS OGDEN JR/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Apr 16, 2025
Application Filed
Oct 28, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12790564
NONIONIC FUNCTIONALIZED POLY ALKYL GLUCOSIDES AS ENHANCERS FOR FOOD SOIL REMOVAL
4y 10m to grant Granted Nov 10, 2026
Patent 12781158
PROCESS OF MAKING A WATER-SOLUBLE UNIT DOSE ARTICLE
3y 5m to grant Granted Nov 03, 2026
Patent 12778869
CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS
3y 4m to grant Granted Nov 03, 2026
Patent 12774433
Zero Waste Soap Container
3y 7m to grant Granted Oct 27, 2026
Patent 12758474
HYDRO-ALCOHOLIC COMPOSITION FOR HAND DISINFECTION
3y 9m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
70%
Grant Probability
93%
With Interview (+23.6%)
2y 8m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1056 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month